Updates are available Correction dated 2019-10-11
Click to view Correction: https://0-doi-org.brum.beds.ac.uk/10.1186/s13054-019-2598-z
-
Authors
Cortegiani, Andrea http://orcid.org/0000-0003-1416-9993
Misseri, Giovanni
Ippolito, Mariachiara
Bassetti, Matteo
Giarratano, Antonino
Martin-Loeches, Ignacio
Einav, Sharon
- License Information
-
More Information
Article History
Received: 8 March 2019
Accepted: 19 May 2019
First Online: 28 May 2019
Change Date: 11 October 2019
Change Type: Correction
Change Details: The author wish to note there are three imprecisions in the article [1].
Ethics approval and consent to participate
: Not applicable
: Not applicable
: IML received fees for lectures from Thermofisher, Polyphor, J&J, Virogates, and MSD and advisory board from Fresenius Kabi, MaaT Pharma, Bayer, Gilead, Clinigen, Biotest, and Accelerate (all unrelated to the present work). AG received fees for consultancies or lectures from Orion, Pfizer, and MSD (all unrelated to the present work). MB has received funding for scientific advisory boards and travel and speaker honoraria from Angelini, AstraZeneca, Bayer, Biomerieux, Cidara, Cubist, Gilead, Pfizer, Melinta Therapeutics, Menarini, MSD, Nabriva, Paratek, Roche, Shionogi, Tetraphase, The Medicines Company, and Astellas Pharma Inc. (all unrelated to the present work). All other authors declare that they have no competing interests.
